CD19CAR-CD28zeta-4-1BB-expressing Allogeneic T Lymphocytes

Allogeneic T-lymphocytes transduced with a retroviral vector expressing a chimeric antigen receptor (CAR) consisting of an anti-CD19 scFv (single chain variable fragment) coupled to the costimulatory signaling domain CD28, the signaling domain of 4-1BB (CD137), and the zeta chain of the T-cell receptor (TCR), with potential immunomodulating and antineoplastic activities. Upon transfusion, CD19CAR-CD28 zeta-4-1BB-expressing allogeneic T lymphocytes directs the T-lymphocytes to and induces selective toxicity in CD19-expressing tumor cells. CD28, a T-cell surface-associated co-stimulatory molecule, is required for T-cell activation, proliferation, and survival. The 4-1BB co-stimulatory molecule signaling domain enhances activation and signaling after recognition of CD19. Furthermore, inclusion of the 4-1BB signaling domain may increase the antitumor activity compared to the inclusion of the CD28 costimulatory domain and TCR zeta chain alone. CD19 antigen is a B-cell specific cell surface antigen, which is expressed in all B-cell lineage malignancies. (NCI Thesaurus)

YOU MAY ALSO LIKE

CD19 wt Allele

Human CD19 wild-type allele is located in the vicinity of 16p11.2 and is approximately 7 kb in length. This allele, which encodes…

CD19 Gene

This gene plays a role in signal transduction and regulates the response of B cells to antigens.

CD19 Expressing Cell Count

The determination of the amount of the CD19 expressing cells in a sample.

CD19 Expressing B Cell Count

The determination of the number of CD19 expressing B cells present in a sample.

CD19 Cell to Lymphocyte Ratio Measurement

The determination of the ratio of CD19 cells compared to lymphocytes present in a sample. The measurement may be expressed as a…

CD19 B Cell to Lymphocyte Ratio Measurement

The determination of the ratio of CD19 B cells compared to lymphocytes present in a sample. The measurement may be expressed as…